FOR RESEARCH USE ONLY
HV Labs / Research field notes

Know the compound.
Read the evidence.

Twenty-five detailed research guides, written to make complex mechanisms readable without flattening the science. Compare pathways, inspect the evidence and understand the laboratory variables behind each compound.

25
Compound guides
12
Research fields
06
Sections per guide
01
Linked calculator
Molecular model of an amino acid chain

Reading the evidence

Not all findings carry the same weight.

01

Established & clinical

Human trials offer stronger evidence, within the limits of each studied population, preparation and endpoint.

02

Early human

Small or regional studies can establish biological activity without settling efficacy or long-term safety.

03

Preclinical & blends

Cell, animal and constituent evidence explains a rationale; it does not prove an outcome in humans.

The complete index

Compound library

25 guidesSorted A–Z
Field note 19Metabolic

AOD9604

Modified C-terminal fragment of human growth hormone researched for lipolysis and fat metabolism.

Adipose metabolismhGH fragment research
Early human research
Field note 01Recovery

BPC-157

Body Protection Compound. Researched for tissue repair, gut health and connective-tissue recovery.

Tendon & ligamentGastrointestinal
Predominantly preclinical
Field note 07Recovery

BPC-157 / TB-500

Pre-mixed BPC-157 and TB500 blend researched for synergistic soft-tissue and connective recovery.

Connective tissueCytoprotection
Constituent evidence only
Field note 21Metabolic

Cagrilintide

Long-acting amylin analogue researched for appetite suppression, satiety and adjunctive weight-management protocols.

Amylin receptorsSatiation
Clinical trial
Field note 03Performance

CJC-1295 / Ipamorelin

Synergistic GHRH + GHRP blend studied for pulsatile endogenous GH support.

GH pulsatilitySecretagogue signalling
Constituent evidence only
Field note 08Sleep

DSIP

Delta Sleep-Inducing Peptide researched for slow-wave sleep architecture and stress modulation.

Slow-wave sleepHPA axis
Early human research
Field note 22Longevity

Epitalon

Synthetic pineal tetrapeptide researched for telomerase activation, circadian regulation and longevity biomarkers.

Telomerase biologyPineal signalling
Early human research
Field note 06Skin

GHK-Cu

Copper-binding tripeptide researched for collagen synthesis, skin remodelling and hair density.

Collagen remodellingCopper biology
Predominantly preclinical
Field note 18Skin

GLOW

Triple-peptide blend of BPC-157, GHK-Cu and TB500 researched for skin, hair and connective-tissue regeneration.

Extracellular matrixSkin models
Constituent evidence only
Field note 23Wellness

Glutathione

Master endogenous tripeptide antioxidant researched for oxidative stress, detoxification, immune support and skin brightening.

Redox balancePhase II metabolism
Clinical trial
Field note 09Performance

Ipamorelin

Selective ghrelin/GHS-R1a agonist researched for clean pulsatile GH release with minimal cortisol or prolactin impact.

GHS-R1aGH release
Early human research
Field note 10Skin

KLOW

Multi-peptide blend (GHK-Cu / Larazotide / Orexin-A / KPV) researched for skin, gut and regenerative protocols.

Intestinal barrierInflammatory signalling
Constituent evidence only
Field note 17Recovery

KPV

Alpha-MSH C-terminal tripeptide researched for anti-inflammatory and gut-mucosal repair applications.

NF-κBMucosal inflammation
Predominantly preclinical
Field note 25Melanocortin

Melanotan II

Synthetic melanocortin receptor agonist researched for melanogenesis, photoprotection and appetite modulation.

MC1R pigmentationMC3R / MC4R
Early human research
Field note 11Metabolic

MOTS-c

Mitochondrial-derived peptide researched for metabolic health, insulin sensitivity and exercise capacity.

AMPKMitochondrial signalling
Early human research
Field note 12Longevity

NAD+

Nicotinamide Adenine Dinucleotide researched for cellular energy, sirtuin activity and longevity protocols.

Redox biologySirtuins & PARPs
Early human research
Field note 05Metabolic

Retatrutide

Investigational triple GIP / GLP-1 / Glucagon receptor agonist with class-leading weight-loss data.

Triple agonismEnergy expenditure
Clinical trial
Field note 13Cognitive

Selank

Synthetic heptapeptide researched for anxiolytic effects, BDNF expression and cognitive performance.

Stress responseNeuroplasticity
Early human research
Field note 04Metabolic

Semaglutide

Long-acting GLP-1 receptor agonist researched for weight, glycaemic and cardiometabolic outcomes.

GLP-1 signallingGlycaemic control
Established clinical
Field note 14Cognitive

Semax

ACTH-fragment analogue researched for neuroprotection, focus and BDNF/NGF upregulation.

BDNF & NGFIschaemic injury
Early human research
Field note 20Mitochondrial

SS-31

Mitochondrial-targeted tetrapeptide (Elamipretide) researched for cardiolipin stabilisation, cellular energy and age-related mitochondrial decline.

CardiolipinMitochondrial cristae
Clinical trial
Field note 02Repair

TB-500

Thymosin Beta-4 active fragment. Researched for soft-tissue repair, angiogenesis and mobility.

Cell migrationSoft tissue
Predominantly preclinical
Field note 15Performance

Tesamorelin

Stabilised GHRH analogue researched for visceral adipose reduction and lean mass support.

GHRH receptorVisceral adipose
Established clinical
Field note 24Immune

Thymosin Alpha-1

Immunomodulatory peptide researched for immune support, vaccine adjuvant activity and viral defence protocols.

T-cell biologyInnate immunity
Clinical trial
Field note 16Metabolic

Tirzepatide

Dual GIP / GLP-1 receptor agonist with class-leading weight and glycaemic outcomes (SURMOUNT / SURPASS).

Dual incretin signallingGlycaemic outcomes
Established clinical

From reference to calculation

Already reading a compound guide?

Each field note links to the calculator with that compound preselected, so the research context stays close to the maths.

Open the calculator

Welcome to HV Labs

Please confirm your age to continue.

For research use only